CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 29, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Read MoreCAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 29, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Read More